title: Cytotoxicity of voriconazole on cultured human corneal endothelial cells.
abstract: The purpose of the present study was to evaluate the toxicity of voriconazole on cultured human corneal endothelial cells (HCECs). HCECs were cultured and exposed to various concentrations of voriconazole (5.0 to 1,000 μg/ml). Cell viability was measured using a Cell Counting Kit-8 (CCK-8) and live/dead viability/cytotoxicity assays. Cell damage was assessed using phase-contrast microscopy after 24 h of exposure to voriconazole. To analyze the effect of voriconazole on the intercellular barrier, immunolocalization of zonula occludens 1 (ZO1) was performed. A flow cytometric assay was performed to evaluate the apoptotic and necrotic effects of voriconazole on HCECs. Cytotoxicity tests demonstrated the dose-dependent toxic effect of voriconazole on HCECs. Voriconazole concentrations of ≥100 μg/ml led to a significant reduction in cell viability. The morphological characteristics of HCECs also changed in a dose-dependent manner. Increasing concentrations of voriconazole resulted in fading staining for ZO1. Higher concentrations of voriconazole resulted in an increased number of propidium iodide (PI)-positive cells, indicating activation of the proapoptotic pathway. In conclusion, voriconazole may have a dose-dependent toxic effect on cultured HCECs. The results of this study suggest that although voriconazole concentrations of up to 50 μg/ml do not decrease cell viability, intracameral voriconazole concentrations of ≥100 μg/ml may increase the risk of corneal endothelial damage.
authors.affiliation: Department of Ophthalmology, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam, Gyeonggi 463-707, South Korea.
authors.forename: Sang Beom
authors.initials: SB
authors.lastname: Han
authors.forename: Young Joo
authors.initials: YJ
authors.lastname: Shin
authors.forename: Joon Young
authors.initials: JY
authors.lastname: Hyon
authors.forename: Won Ryang
authors.initials: WR
authors.lastname: Wee
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004396:Coloring Agents; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects*; D004728:Endothelium, Corneal / Q000166:cytology / Q000187:drug effects*; D005434:Flow Cytometry; D006801:Humans; D008565:Membrane Proteins / Q000032:analysis; D009336:Necrosis; D010750:Phosphoproteins / Q000032:analysis; D011419:Propidium; D011743:Pyrimidines / Q000494:pharmacology / Q000633:toxicity*; D014230:Triazoles / Q000494:pharmacology / Q000633:toxicity*; D065819:Voriconazole; D062826:Zonula Occludens-1 Protein
chemical_list: D004396:Coloring Agents; D008565:Membrane Proteins; D010750:Phosphoproteins; D011743:Pyrimidines; C569042:TJP1 protein, human; D014230:Triazoles; D062826:Zonula Occludens-1 Protein; D011419:Propidium; D065819:Voriconazole